Myomo, Inc. (MYO) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Myomo, Inc. (MYO) closed at USD 1.24 on 2026-10-14, a change of +21.6 % over the past year, with a market capitalization of USD 51.49M.

Myomo, Inc. recent closing prices

DateClose (USD)
2026-10-141.24
2026-10-131.29
2026-10-121.36
2026-10-091.43
2026-10-081.41
2026-10-071.45
2026-10-061.61

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Myomo, Inc. key figures

Previous close
USD 1.24 (2026-10-14)
1-year change
+21.6 %
Market cap
USD 51.49M
Enterprise value
USD 58.12M
P/E ratio (trailing)
-3.71
P/E ratio (forward)
-5.91
EPS (trailing)
-0.35
EPS (forward)
-0.22
PEG ratio
n/a
Price to book
8.84
Revenue growth
21.3 %
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
2.81
Employees
194
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Myomo, Inc. and compare it with other stocks.

Analyze MYOAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Myomo, Inc. shares.